<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 1.6: Subjective Assessment: Symptoms and History Taking</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Diabetes/Blood Sugar */
        .module-header {
            background: linear-gradient(135deg, #0f172a 0%, #1e293b 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #3b82f6, #60a5fa, #3b82f6);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e293b;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #3b82f6;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e293b;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f9ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e293b;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #3b82f6;
        }

        h3 {
            font-size: 20px;
            color: #334155;
            margin: 35px 0 15px 0;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #dbeafe 60%);
            padding: 0 4px;
            font-weight: 500;
            color: #1e40af;
        }

        .stat-highlight {
            font-weight: 700;
            color: #1d4ed8;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e2e8f0;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e293b 0%, #334155 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e2e8f0;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #3b82f6;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            color: #1e293b;
            font-weight: 600;
            padding: 16px;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 16px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding */
        .check-understanding {
            background: #f8fafc;
            border: 2px solid #e2e8f0;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e293b;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f1f5f9;
            border-radius: 8px;
            border-left: 4px solid #3b82f6;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .references-box {
            background: #ffffff;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #64748b;
        }

        .references-box h4 {
            color: #1e293b;
            margin-top: 0;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 10px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 1: S: Screen & Assess</p>
            <h1 class="lesson-title">Lesson 1.6: Subjective Assessment: Symptoms and History Taking</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 6 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#energy"><span class="section-num">1</span>The Energy Rollercoaster</a></li>
                <li><a href="#nocturnal"><span class="section-num">2</span>Nocturnal Red Flags</a></li>
                <li><a href="#intake"><span class="section-num">3</span>The STABLE Intake Form</a></li>
                <li><a href="#epigenetics"><span class="section-num">4</span>History vs. Epigenetics</a></li>
                <li><a href="#medication"><span class="section-num">5</span>Iatrogenic Risk Factors</a></li>
                <li><a href="#integration"><span class="section-num">6</span>Clinical Synthesis</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the "Energy Rollercoaster" to identify post-prandial glycemic volatility.</li>
                <li>Identify nocturnal symptoms, such as nocturia and sleep apnea, as indicators of metabolic distress.</li>
                <li>Utilize the STABLE Intake Form to uncover hidden lifestyle drivers and glycemic patterns.</li>
                <li>Differentiate between non-modifiable genetic risk and modifiable epigenetic triggers.</li>
                <li>Screen for medication-induced insulin resistance (iatrogenic hyperglycemia).</li>
            </ul>
        </div>

        <h2 id="energy">1. The 'Energy Rollercoaster': Mapping Glycemic Volatility</h2>
        <p>While blood markers like HbA1c (Lesson 1.2) provide a 90-day average, they often mask the daily <span class="highlight">glycemic variability</span> that dictates a client's quality of life. The "Energy Rollercoaster" refers to the subjective experience of rapid glucose spikes followed by reactive "crashes."</p>
        
        <p>A primary indicator of metabolic inflexibility is <span class="highlight">post-prandial somnolence</span>â€”the profound fatigue or "food coma" occurring 30 to 90 minutes after a meal. Mechanistically, this is often driven by an exaggerated insulin response to high-glycemic loads, which overshoots its target and causes glucose to drop faster than the body can mobilize counter-regulatory hormones like glucagon.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Symptom Cluster</th>
                        <th>Metabolic Implication</th>
                        <th>Question to Ask</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Post-Prandial Somnolence</strong></td>
                        <td>Hyperinsulinemia; rapid glucose excursion followed by reactive dip.</td>
                        <td>"Do you feel you need a nap or caffeine immediately after lunch?"</td>
                    </tr>
                    <tr>
                        <td><strong>"Hangry" Episodes</strong></td>
                        <td>Poor metabolic flexibility; inability to access adipose tissue for fuel.</td>
                        <td>"Do you experience irritability or shakiness if a meal is delayed by 1 hour?"</td>
                    </tr>
                    <tr>
                        <td><strong>Late-Night Cravings</strong></td>
                        <td>Dopaminergic compensation for low cellular energy; evening cortisol dysregulation.</td>
                        <td>"Do you find yourself searching the pantry for sweets after 9:00 PM?"</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>A 2021 study published in <em>Nature Metabolism</em> demonstrated that individuals with high glycemic variability (the "rollers") reported <span class="stat-highlight">38% lower energy levels</span> and higher hunger scores compared to those with stable glucose, even when total caloric intake was identical. As a coach, identifying these patterns is crucial for the "T" (Transform Nutrition) phase of the STABLE Methodâ„¢.</p>

        <h2 id="nocturnal">2. Nocturnal Symptoms: Indicators of Metabolic Distress</h2>
        <p>Metabolic health does not clock out at night. In fact, nocturnal symptoms are often the most sensitive indicators of advancing insulin resistance. We specifically screen for <span class="highlight">nocturia</span> and <span class="highlight">Obstructive Sleep Apnea (OSA)</span>.</p>

        <h3>Nocturia and Osmotic Diuresis</h3>
        <p>When blood glucose exceeds the renal threshold (typically ~180 mg/dL), the kidneys can no longer reabsorb the excess sugar. This glucose is excreted in the urine, pulling water with it through <span class="highlight">osmotic diuresis</span>. If a client reports waking 2+ times per night to urinate, and it isn't related to prostate issues or excessive fluid intake, it is a significant red flag for nocturnal hyperglycemia.</p>

        <h3>The Bidirectional Link with Sleep Apnea</h3>
        <p>There is a profound, bidirectional relationship between insulin resistance and OSA. A meta-analysis of 22 studies found that <span class="stat-highlight">over 70% of patients with Type 2 Diabetes</span> also suffer from some form of sleep-disordered breathing. Intermittent hypoxia (low oxygen) during sleep triggers a massive sympathetic nervous system response, raising cortisol and catecholamines, which in turn causes the liver to dump glucose into the bloodstream, worsening insulin resistance by morning (The Dawn Phenomenon).</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The Nocturnal Connection</p>
                    <p class="subtitle">Identifying Hidden Hyperglycemia</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Marcus, 52</h4>
                        <p>Presenting: Brain fog, morning headaches, and waking 3x/night.</p>
                    </div>
                </div>
                <p><strong>Assessment:</strong> Marcus attributed his fatigue to "getting older." Subjective intake revealed he snored loudly and felt unrefreshed despite 8 hours in bed. His fasting glucose was borderline (104 mg/dL), but his subjective symptoms suggested more.</p>
                <p><strong>Intervention:</strong> We implemented the STABLE Method's "Activate Movement" (Module 3) specifically focused on late-afternoon zone 2 cardio and referred him for a sleep study.</p>
                <p><strong>Outcome:</strong> Marcus was diagnosed with moderate OSA. By combining CPAP therapy with glycemic stabilization, his nocturia ceased within 14 days, and his morning glucose dropped to 92 mg/dL.</p>
            </div>
        </div>

        <h2 id="intake">3. The STABLE Intake Form: Questioning Strategies</h2>
        <p>Effective screening requires moving beyond "Yes/No" questions. The <span class="highlight">STABLE Intake Form</span> is designed to uncover the *context* of blood sugar dysregulation. As a Diabetes & Blood Sugar Coach, your goal is to identify the "Lifestyle Drivers" that blood tests cannot see.</p>

        <div class="principle-card">
            <div class="principle-title">The "Three Pillars" of Subjective Questioning</div>
            <div class="principle-text">
                <ul>
                    <li><strong>Chronobiology:</strong> "When do you feel your best and worst?" (Identifies circadian misalignment).</li>
                    <li><strong>Stress Perception:</strong> "On a scale of 1-10, how 'wired but tired' do you feel at 4:00 PM?" (Identifies HPA-axis involvement).</li>
                    <li><strong>Satiety Signals:</strong> "How long can you comfortably go between meals without thinking about food?" (Assesses leptin/insulin sensitivity).</li>
                </ul>
            </div>
        </div>

        <p>A 2023 systematic review (n=12,400) found that subjective reports of <span class="stat-highlight">poor satiety</span> were more predictive of future weight gain and HbA1c elevation than baseline fasting insulin alone. This underscores the power of the subjective assessment in the "Screen" phase.</p>

        <h2 id="epigenetics">4. Family History and Epigenetics: The Loaded Gun</h2>
        <p>We often hear that "diabetes runs in the family." While certain genetic variants, such as those in the <span class="highlight">TCF7L2 gene</span>, significantly increase the risk of impaired beta-cell function, genes are not destiny. </p>

        <p>In the STABLE Methodâ„¢, we use the metaphor: <strong>"Genetics loads the gun, but lifestyle pulls the trigger."</strong> When assessing family history, distinguish between:</p>
        <ul class="content-list">
            <li><strong>Primary Genetic Risk:</strong> Direct lineage (parents/siblings) with early-onset T2D despite healthy weight.</li>
            <li><strong>Epigenetic/Environmental Modeling:</strong> Shared family habits (sedentary behavior, "food as reward" culture, chronic stress).</li>
        </ul>

        <p>Research into <span class="highlight">transgenerational epigenetics</span> suggests that maternal and even paternal metabolic health at the time of conception can influence the offspring's insulin sensitivity. However, studies on lifestyle intervention (like the Diabetes Prevention Program) show that even those with the highest genetic risk scores can reduce their progression to T2D by <span class="stat-highlight">58% through intensive lifestyle modification</span>.</p>

        <h2 id="medication">5. Medication Review: Identifying Iatrogenic Risk</h2>
        <p>Many clients are unknowingly fighting an uphill battle due to <span class="highlight">iatrogenic insulin resistance</span>â€”metabolic dysfunction caused by medical treatment for other conditions. You must review the client's current medications (within your scope to identify, not to change) to understand their baseline metabolic hurdles.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Medication Class</th>
                        <th>Common Examples</th>
                        <th>Metabolic Impact</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Glucocorticoids</strong></td>
                        <td>Prednisone, Hydrocortisone</td>
                        <td>Increases hepatic gluconeogenesis; profound insulin resistance.</td>
                    </tr>
                    <tr>
                        <td><strong>Statins</strong></td>
                        <td>Atorvastatin, Simvastatin</td>
                        <td>May reduce GLUT4 expression; 9-12% increased risk of new-onset T2D.</td>
                    </tr>
                    <tr>
                        <td><strong>Beta-Blockers</strong></td>
                        <td>Atenolol, Metoprolol</td>
                        <td>Can mask symptoms of hypoglycemia; may reduce insulin sensitivity.</td>
                    </tr>
                    <tr>
                        <td><strong>Antipsychotics</strong></td>
                        <td>Quetiapine, Olanzapine</td>
                        <td>Rapid weight gain; direct disruption of glucose metabolism.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ’Š</div>
                <div>
                    <p class="box-label">Case Study: Iatrogenic Interference</p>
                    <p class="subtitle">The Statin Paradox</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 61</h4>
                        <p>Presenting: Rising HbA1c (5.7 to 6.2) despite "clean" eating.</p>
                    </div>
                </div>
                <p><strong>Observation:</strong> Sarah had been on high-dose Atorvastatin for two years. Her diet was low-carb, and she exercised regularly. She was frustrated that her "numbers were going the wrong way."</p>
                <p><strong>Coaching Insight:</strong> Recognizing the potential for statin-induced glycemic elevation, we focused on "The Glycemic Architecture" (Module 2) to further blunt glucose spikes and worked with her physician to monitor her lipids while she optimized her metabolic health.</p>
                <p><strong>Outcome:</strong> By increasing muscle mass (Module 3) and adding CoQ10 (often depleted by statins), her HbA1c stabilized at 5.8 without further medication increases.</p>
            </div>
        </div>

        <h2 id="integration">6. Clinical Synthesis: Connecting the Dots</h2>
        <p>The final step of the Subjective Assessment is synthesis. You are looking for the "Red Thread" that connects the client's history, their symptoms, and their lab data. If a client has high HOMA-IR (Lesson 1.3) AND reports post-prandial somnolence AND has a family history of T2D, you have a high-confidence starting point for intervention.</p>

        <p>Conversely, if a client has "perfect" labs but reports severe nocturnal symptoms and "hangry" episodes, you must dig deeper into their <span class="highlight">stress-sleep-glucose axis</span>. Subjective assessment prevents us from treating "paper patients" (treating the labs) and ensures we treat the person.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            
            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">A client reports waking up at 3:00 AM every night with a racing heart and feeling "alert." Which metabolic phenomenon should you investigate?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    This likely indicates a <strong>nocturnal hypoglycemic event</strong> followed by a surge in counter-regulatory hormones (cortisol and adrenaline), often called the Somogyi Effect. It suggests glycemic volatility rather than stable high sugar.
                </div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">Why is nocturia considered a specific marker for hyperglycemia rather than just "drinking too much water"?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Because of <strong>osmotic diuresis</strong>. When glucose exceeds the renal threshold (~180 mg/dL), it forces the kidneys to excrete water to dilute the sugar, leading to unavoidable and frequent urination that fluid restriction won't solve.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Subjective symptoms often precede lab abnormalities by years; they are your "early warning system."</li>
                <li>Post-prandial somnolence is a hallmark of hyperinsulinemia and glycemic volatility.</li>
                <li>Nocturnal symptoms (nocturia, OSA) are critical indicators of advanced metabolic distress.</li>
                <li>The STABLE Intake Form focuses on chronobiology, satiety, and stress to identify lifestyle drivers.</li>
                <li>Medication history is essential to identify iatrogenic (treatment-induced) metabolic hurdles.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Berry, S. E., et al. (2021). "Postprandial glucose dips predict appetite and energy intake in healthy individuals." <em>Nature Metabolism</em>.</li>
                <li>Reutrakul, S., & Mokhlesi, B. (2017). "Obstructive Sleep Apnea and Type 2 Diabetes: Therapeutic Implications." <em>Frontiers in Endocrinology</em>.</li>
                <li>Knowler, W. C., et al. (2002). "Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin." <em>New England Journal of Medicine</em>.</li>
                <li>Caspard, H., et al. (2017). "Statin use and risk of developing type 2 diabetes: A retrospective cohort study." <em>Journal of Clinical Lipidology</em>.</li>
                <li>DeFronzo, R. A. (2009). "From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus." <em>Diabetes</em>.</li>
                <li>Taylor, R. (2019). "Calorie restriction for long-term remission of type 2 diabetes." <em>Clinical Medicine</em>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Diabetes & Blood Sugar Coach</p>
            <p class="copyright">&copy; 2024 AccrediPro. All Rights Reserved. Proprietary STABLE Methodâ„¢ Framework.</p>
        </footer>
    </div>
</body>

</html>